Difference between revisions of "Sulfadiazine"

From Self-sufficiency
Jump to: navigation, search
m (1 revision)
m (1 revision)
 
(One intermediate revision by one other user not shown)
Line 48: Line 48:
  
  
{{pharma-stub}}
 
  
 
{{Sulfonamides and trimethoprim}}
 
{{Sulfonamides and trimethoprim}}
 
{{Antiprotozoal agent}}
 
{{Antiprotozoal agent}}
 +
 +
 +
{{antiinfective-drug-stub}}
  
 
[[es:Sulfadiazina]]
 
[[es:Sulfadiazina]]

Latest revision as of 12:11, 20 September 2010

Sulfadiazine
250px
250px
Systematic (IUPAC) name
4-amino-N-pyrimidin- 2-yl-benzenesulfonamide
Clinical data
Pregnancy
category
  •  ?
Routes of
administration
Cream
Legal status
Legal status
  • Approved Drug
Pharmacokinetic data
Bioavailability ?
Metabolism ?
Biological half-life ?
Excretion ?
Identifiers
CAS Number 68-35-9
ATC code J01EC02 (WHO) QJ01EQ10
PubChem CID 5215
DrugBank APRD00190
Chemical data
Formula C10H10N4O2S
Molar mass 250.278 g/mol[[Script error: No such module "String".]]
  (verify)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Sulfadiazine is a sulfonamide antibiotic.

Uses

It eliminates bacteria that cause infections by stopping the production of folic acid inside the bacterial cell, and is commonly used to treat urinary tract infections (UTIs).

In combination, sulfadiazine and pyrimethamine, can be used to treat toxoplasmosis, a disease caused by Toxoplasma gondii.

Side effects

Side effects reported for sulfadiazine include: nausea, upset stomach, loss of appetite, and dizziness.

Brand names

Lantrisul; Neotrizine; Sulfa-Triple #2; Sulfadiazine; Sulfaloid; Sulfonamides Duplex; Sulfose; Terfonyl; Triple Sulfa; Triple Sulfas; Triple Sulfoid

See also

External links



es:Sulfadiazina

it:Sulfadiazina ja:スルファジアジン pt:Sulfadiazina ru:Сульфадиазин натрий th:ซัลฟาไดอะซีน